151 related articles for article (PubMed ID: 18205601)
41. Expression of vascular endothelial growth factor and its receptors in canine lymphoma.
Wolfesberger B; Guija de Arespacohaga A; Willmann M; Gerner W; Miller I; Schwendenwein I; Kleiter M; Egerbacher M; Thalhammer JG; Muellauer L; Skalicky M; Walter I
J Comp Pathol; 2007 Jul; 137(1):30-40. PubMed ID: 17467003
[TBL] [Abstract][Full Text] [Related]
42. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204
[TBL] [Abstract][Full Text] [Related]
43. Effect of chemotherapeutic stress on induction of vascular endothelial growth factor family members and receptors in human colorectal cancer cells.
Fan F; Gray MJ; Dallas NA; Yang AD; Van Buren G; Camp ER; Ellis LM
Mol Cancer Ther; 2008 Sep; 7(9):3064-70. PubMed ID: 18790786
[TBL] [Abstract][Full Text] [Related]
44. Increased angiogenesis and expression of vascular endothelial growth factor during scarless repair.
Colwell AS; Beanes SR; Soo C; Dang C; Ting K; Longaker MT; Atkinson JB; Lorenz HP
Plast Reconstr Surg; 2005 Jan; 115(1):204-12. PubMed ID: 15622252
[TBL] [Abstract][Full Text] [Related]
45. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
[TBL] [Abstract][Full Text] [Related]
46. Structural determinants of growth factor binding and specificity by VEGF receptor 2.
Leppänen VM; Prota AE; Jeltsch M; Anisimov A; Kalkkinen N; Strandin T; Lankinen H; Goldman A; Ballmer-Hofer K; Alitalo K
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2425-30. PubMed ID: 20145116
[TBL] [Abstract][Full Text] [Related]
47. [Advances of research on vascular endothelial growth factor receptors in epidermal neoplasm].
YANG P; ZHENG M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):422-6. PubMed ID: 19693983
[TBL] [Abstract][Full Text] [Related]
48. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
49. Quantitative real-time reverse transcription PCR study of the expression of vascular endothelial growth factor (VEGF) splice variants and VEGF receptors (VEGFR-1 and VEGFR-2) in non small cell lung cancer.
Zygalaki E; Tsaroucha EG; Kaklamanis L; Lianidou ES
Clin Chem; 2007 Aug; 53(8):1433-9. PubMed ID: 17599955
[TBL] [Abstract][Full Text] [Related]
50. Differential expression of VEGF ligands and receptors in prostate cancer.
Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
[TBL] [Abstract][Full Text] [Related]
51. Expression and localization of VEGF receptors in human fetal skeletal tissues.
Marini M; Sarchielli E; Toce M; Acocella A; Bertolai R; Ciulli C; Orlando C; Sgambati E; Vannelli GB
Histol Histopathol; 2012 Dec; 27(12):1579-87. PubMed ID: 23059888
[TBL] [Abstract][Full Text] [Related]
52. Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors.
Li M; Yang H; Chai H; Fisher WE; Wang X; Brunicardi FC; Yao Q; Chen C
Cancer; 2004 Nov; 101(10):2341-50. PubMed ID: 15476280
[TBL] [Abstract][Full Text] [Related]
53. Quantification of VEGF isoforms and VEGFR transcripts by qRT-PCR and their significance in acute myeloid leukemia.
Mourah S; Porcher R; Lescaille G; Rousselot P; Podgorniak MP; Labarchède G; Naimi B; Medioni J; Dombret H; Calvo F
Int J Biol Markers; 2009; 24(1):22-31. PubMed ID: 19404919
[TBL] [Abstract][Full Text] [Related]
54. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
Park HR; Min K; Kim HS; Jung WW; Park YK
Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
[TBL] [Abstract][Full Text] [Related]
55. Functional relevance of the switch of VEGF receptors/co-receptors during peritoneal dialysis-induced mesothelial to mesenchymal transition.
Pérez-Lozano ML; Sandoval P; Rynne-Vidal A; Aguilera A; Jiménez-Heffernan JA; Albar-Vizcaíno P; Majano PL; Sánchez-Tomero JA; Selgas R; López-Cabrera M
PLoS One; 2013; 8(4):e60776. PubMed ID: 23585849
[TBL] [Abstract][Full Text] [Related]
56. Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas.
Munaut C; Noël A; Hougrand O; Foidart JM; Boniver J; Deprez M
Int J Cancer; 2003 Oct; 106(6):848-55. PubMed ID: 12918061
[TBL] [Abstract][Full Text] [Related]
57. Expression of VEGF receptors in cocultured neuroblastoma cells.
Beierle EA; Dai W; Langham MR; Copeland EM; Chen MK
J Surg Res; 2004 Jun; 119(1):56-65. PubMed ID: 15126083
[TBL] [Abstract][Full Text] [Related]
58. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
59. Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-C on corneal dendritic cells.
Hamrah P; Chen L; Zhang Q; Dana MR
Am J Pathol; 2003 Jul; 163(1):57-68. PubMed ID: 12819011
[TBL] [Abstract][Full Text] [Related]
60. The effects of vascular endothelial growth factor (VEGF) on human orbital preadipocyte.
Choi HY; Jung J; Name SB; Lee JE; Byon IS; Seo JH
Orbit; 2016; 35(1):6-10. PubMed ID: 26588326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
